All VFC/VFAAR influenza vaccines supplied by the Philadelphia Immunization Program during the 2023-2024 flu season have expired. Please account for unused VFC/VFAAR flu vaccine at your site using PhilaVax:
Process a return for the unopened vials online in the Vaccine Returns module. A job aid with step-by-step instructions can be found here.
Adjust out open multi dose vials of flu. A job aid with step-by-step instructions can be found here.
Return your vaccine before July 22
Please complete these steps by July 22, 2024 to avoid delays in processing your site’s 2024-2025 flu season orders. If you have any questions or need assistance, contact DPHProviderHelp@phila.gov.
All communication about flu vaccine availability will be made via email and posted on ourwebsite. Keep an eye out for upcoming messages!
Thank you for protecting Philadelphians this past year. We look forward to working together to keep people safe from the flu next season.
2023-2024 Pfizer (5 yrs-11 yrs and 12+) COVID-19 Vaccines No Longer Available
As of Monday, June 10, 2024, the Pfizer 2023-2024 COVID-19 vaccine, 5 yrs – 11 yrs, and Comirnaty (Pfizer), 2023-2024 COVID-19 vaccine, 12 yrs + products are no longer available to order through the Vaccines for Children (VFC) and Bridge Access Programs.
Continue to order and administer 2023-2024 COVID-19 vaccines until they reach their beyond use date (BUD), expire, or new product becomes available. We’ve seen summer peaks in past years, so individuals aged 6 months and above who have not received a dose should continue to be vaccinated.
See below for details on the availability of the different products. If your preferred product is no longer available, change to an alternate product and continue to offer and administer COVID-19 vaccine to patients.
Available Products (updated 6/10/2024): 2023-2024 COVID-19 Vaccine
Upcoming Changes in COVID-19 Vaccine Product Availability
CDC anticipates upcoming changes in the availability of COVID-19 vaccine products.
Here’s what we know now about the upcoming changes in 2023-2024 COVID-19 product availability:
The latest expiration date for the Pfizer (6 mo – 4 yrs) product is 7/31/2024.
Moderna (6 mo – 11 yrs and 12+) product has expiration dates through late September.
Be sure to check expiration dates before administering any vaccine.
Other Considerations for COVID-19 Vaccine Product Expiration
The expiration dates indicated above are the latest 2023-2024 expiry. Your office may have vaccine products that expire sooner.
The beyond use date (BUD) supersedes the manufacturer’s expiration date.
We will send additional messages to remind you about these expiration dates as they occur, provide guidance for inventory management, and inform you of other product updates as we are notified.
If you have questions about COVID-19 vaccine availability, please reach out.
See below for details on the availability of different products. If your preferred product is no longer available, change to an alternate product and continue to offer and administer COVID-19 vaccine to patients.
Available Products (updated 6/3/2024): 2023-2024 COVID-19 Vaccine
Upcoming Changes in COVID-19 Vaccine Product Availability
CDC anticipates upcoming changes in the availability of COVID-19 vaccine products.
Here’s what we know now about the upcoming changes in product availability:
The latest expiration dates of the 2023-24 COVID-19 season NovaVax and Pfizer products are:
Novavax: 5/31/2024
Pfizer (6 mo – 4 yrs): 7/31/2024
Pfizer (5 yrs – 11 yrs and 12+): 8/31/2024
Moderna (6 mo – 11 yrs and 12+) products have expiration dates through late September
Be sure to check expiration dates before administering any vaccine.
Other Considerations for COVID-19 Vaccine Product Expiration
The expiration dates indicated above are the latest 2023-2024 expiry. Your office may have vaccine products that expire sooner.
The beyond use date (BUD) supersedes the manufacturer’s expiration date.
We will send additional messages to remind you about these expiration dates as they occur, provide guidance for inventory management, and inform you of other product updates as we are notified.
If you have questions about COVID-19 vaccine availability, please reach out.
Important: VFC & VFAAR orders submitted to PhilaVax without temperature data will be rejected. *
We will no longer contact VFC & VFAAR sites to request missing temperature data after the order date. VFC & VFAAR orders will be rejected, and the provider will need to resubmit their order. Remember, a new reconciliation must be completed after two business days to process the order.
Uploading temperature data to PhilaVax and emailing the data to TempCheck@phila.gov have been requirements for several years. The data you submit to the TempCheck team is analyzed for excursions and potential unit malfunctions, helping us maintain our quality control standards. The data submitted to PhilaVax facilitates timely ordering for our 200+ providers throughout the city.
These guides can assist you in submitting your DDL temperature files:
Temperature data must be submitted to PhilaVax and emailed to TempCheck@phila.gov every 28 days and when an order is placed.
Submit temperature data up to and including the day of vaccine order.
For example, if you submit temperature data on Monday and place your order on Tuesday, you must submit temperatures again on Tuesday, or your order will be rejected.
After placing an order, it’s important to check its status within two business days. If the order is rejected, carefully review the VFC comments for instructions on resubmitting it. Remember, a new reconciliation must be completed after two business days to process the order.
Call for Nominations: 2024 Immunization Champion Award
You can still submit a nomination for the Immunization Champion Award! Your nominations will determine the 2024 Philadelphia Immunization Champion. Check out the eligibility criteria below and acknowledge someone you know who champions local immunization access.
The Immunization Champion Award is a national award program hosted by the Association of Immunization Managers (AIM) and honors individuals going above and beyond to foster and/or promote immunization in their communities.
Access the nomination form below. Once completed, email it to vaccines@phila.gov!
New Vaccine Product Available Through VFC: Penbraya (MenABCWY)
On October 20, 2023, the FDA licensed Pfizer’s pentavalent vaccine Penbraya to prevent meningococcal serogroups A, B, C, W, and Y.
As a reminder, MenB vaccines are not interchangeable. The same vaccine (either Bexsero by GSK or Trumenba by Pfizer) must be used for all doses in the MenB series, including booster doses. The pentavalent MenABCWY product Penbraya (Pfizer) contains MenB-Fhbp (Trumenba) as its MenB component; therefore, Penbraya should only be used in series with Trumenba.
To add this formulation to the list of vaccines that your site orders, use the button below to complete the change request form.
Our team will review your request and reply with next steps. We recommend that sites that are affiliated or part of a system use the same vaccine presentations across sites to ensure continuity of care and help prevent administration errors.
To purchase this vaccine in the private market, please contact your local Pfizer sales rep at brian.bengston@pfizer.com.
Penbraya 1 Dose Kit and Penbraya 5 Dose Kit are now available through the Vaccines for Children (VFC) program.
The Advisory Committee on Immunization Practices (ACIP) recommends MenABCWY for ages 10 through 25. Penbraya may be used when both MenACWY and MenB are indicated at the same visit. More specifically, MenABCWY is recommended for the following groups based on shared clinical decision-making:
Healthy individuals aged 16 to 23 years due for their MenACWY booster and MenB vaccination at the same visit.
Children 10 years and older with complement deficiency, functional or anatomic asplenia (including sickle cell disease), or receiving complement inhibitors.
Congratulations to last week’s survey winner: Puentes De Salud! But wait, there’s another chance to win and help us better prepare for the next flu season! We will hold a second drawing to win a free buzzy.
To enter our second drawing, use the button below to complete a short survey (less than 3 minutes) by Friday, May 17, 2024.
If you previously filled out the survey, you’ve already entered. Your responses are key to our 2024-2025 flu season planning!
Review the dosing schedule and available products for 2023-2024 COVID-19 vaccine below. We don’t yet know the exact timing of when 2024–2025 COVID-19 vaccines will be available. However, FDA authorization or approval of 2024–2025 COVID-19 vaccines is anticipated for Fall 2024.
See the table below for details on the availability of the different products. If your preferred product is no longer available, change to an alternate product to continue offering and administering COVID-19 vaccine to patients.
Available Products (updated 5/2/24): 2023-2024 COVID-19 Vaccine
Tips for COVID-19 Vaccine Ordering & Administration
Continue to order and administer 2023-2024 COVID-19 vaccines until they reach their beyond use date (BUD), expire, or new product becomes available.
Theremaining 2023-2024 COVID-19 vaccines available for ordering are expected to expire between May and July. It is important to check expiration dates before administering any vaccine.
We’ve seen summer peaks in COVID-19 cases in past years, so individuals aged 6 months and above who have not received a dose should continue to be vaccinated.
If you have questions about COVID-19 vaccine availability, please reach out.
We’re sending pediatric and adult materials to your office. Preview some of the print materials that are on the way, and order more in different languages!
Preview: Laminated Pediatric Vaccine Schedule
Preview: RSV Palm Card for Adults
Visit our website to order more free print materials for your office.
Once you have found the materials you want, make a note of their ID#s and head over to the corresponding online ordering form. We recommend opening the online ordering form in a separate tab. This will let you easily switch between the online ordering form and the image galleries.
If you have questions or need help with the ordering process, email us at vaccines@phila.gov.
